Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CVS Stock Forecast 2026-2027
$77.36
Current Price
$99.14B
Market Cap
Buy 24
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to CVS Price Targets
+81.0%
To High Target of $140.00
+24.1%
To Median Target of $96.00
+2.1%
To Low Target of $79.00
CVS Price Momentum
+3.2%
1 Week Change
+8.2%
1 Month Change
+18.2%
1 Year Change
-2.5%
Year-to-Date Change
-9.1%
From 52W High of $85.15
+32.6%
From 52W Low of $58.35
📊 TOP ANALYST CALLS
Did CVS Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if CVS is one of their latest high-conviction picks.
Latest CVS Stock Price Targets & Analyst Predictions
Based on our analysis of 43 Wall Street analysts, CVS has a bullish consensus with a median price target of $96.00 (ranging from $79.00 to $140.00). The overall analyst rating is Strong Buy (9.1/10). Currently trading at $77.36, the median forecast implies a 24.1% upside. This outlook is supported by 24 Buy, 3 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Kevin Caliendo at UBS, suggesting a 2.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CVS Analyst Ratings
24
Buy
3
Hold
0
Sell
CVS Price Target Range
Low
$79.00
Average
$96.00
High
$140.00
Current: $77.36
Latest CVS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CVS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 15, 2026 | Baird | Michael Ha | Outperform | Maintains | $94.00 |
| Mar 31, 2026 | Piper Sandler | Jessica Tassan | Overweight | Maintains | $99.00 |
| Mar 12, 2026 | Bernstein | Lance Wilkes | Outperform | Upgrade | $94.00 |
| Jan 28, 2026 | Argus Research | Steve Silver | Buy | Maintains | $90.00 |
| Jan 27, 2026 | B of A Securities | Michael Cherny | Buy | Maintains | $95.00 |
| Jan 6, 2026 | Bernstein | Market Perform | Maintains | $N/A | |
| Dec 17, 2025 | JP Morgan | Lisa Gill | Overweight | Maintains | $101.00 |
| Dec 12, 2025 | Bernstein | Lance Wilkes | Market Perform | Maintains | $87.00 |
| Dec 10, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $97.00 |
| Dec 10, 2025 | Truist Securities | David Macdonald | Buy | Maintains | $98.00 |
| Dec 10, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $93.00 |
| Dec 10, 2025 | Mizuho | Ann Hynes | Outperform | Maintains | $95.00 |
| Dec 10, 2025 | Baird | Michael Ha | Outperform | Maintains | $92.00 |
| Dec 10, 2025 | Morgan Stanley | Erin Wright | Overweight | Maintains | $93.00 |
| Dec 10, 2025 | Piper Sandler | Jessica Tassan | Overweight | Reiterates | $101.00 |
| Dec 5, 2025 | Bernstein | Lance Wilkes | Market Perform | Maintains | $86.00 |
| Nov 13, 2025 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $102.00 |
| Nov 3, 2025 | TD Cowen | Charles Rhyee | Buy | Maintains | $100.00 |
| Oct 30, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $93.00 |
| Oct 30, 2025 | Truist Securities | David Macdonald | Buy | Reiterates | $95.00 |
CVS Health Corporation (CVS) Competitors
The following stocks are similar to CVS based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
CVS Health Corporation (CVS) Financial Data
CVS Health Corporation has a market capitalization of $99.14B with a P/E ratio of 55.6x. The company generates $399.83B in trailing twelve-month revenue with a 0.4% profit margin.
Revenue growth is +8.4% quarter-over-quarter, while maintaining an operating margin of +1.6% and return on equity of +2.3%.
Valuation Metrics
Market Cap
$99.14B
Enterprise Value
$167.86B
P/E Ratio
55.6x
PEG Ratio
0.7x
Price/Sales
0.2x
Growth & Margins
Revenue Growth (YoY)
+8.4%
Gross Margin
+12.8%
Operating Margin
+1.6%
Net Margin
+0.4%
EPS Growth
+79.0%
Financial Health
Cash/Price Ratio
+10.8%
Current Ratio
0.8x
Debt/Equity
106.1x
ROE
+2.3%
ROA
+2.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
CVS Health Corporation (CVS) Business Model
About CVS Health Corporation
What They Do
Healthcare services integrating pharmacy and insurance.
Business Model
CVS Health Corporation generates revenue through various segments, including retail pharmacy, pharmacy benefits management, and health insurance services. The company operates the largest retail pharmacy chain in the U.S., fills a significant portion of prescriptions, and provides pharmacy benefits management services to employers and insurers, along with health insurance through Aetna.
Additional Information
Founded in 1963 and headquartered in Woonsocket, Rhode Island, CVS Health is the world's second-largest healthcare company, employing around 300,000 people. It offers a wide range of services including specialty therapies and primary care centers, significantly enhancing access to medications and integrated healthcare solutions nationwide.
Company Information
Sector
Healthcare
Industry
Healthcare Plans
Employees
219,000
CEO
Mr. J. David Joyner CEBS
Country
United States
IPO Year
1984
Website
www.cvshealth.comCVS Health Corporation (CVS) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Why CVS Health (CVS) is Poised to Beat Earnings Estimates Again
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Apr 21, 2026
By Zacks Equity Research
Tale of the Tape
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
In the latest trading session, CVS Health (CVS) closed at $78.09, marking a -1.56% move from the previous day.
Apr 13, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
CVS Health (CVS) has a strong earnings surprise history and favorable conditions for a potential beat in its upcoming quarterly report.
Why It Matters
CVS's strong earnings surprise history and favorable conditions suggest potential positive performance in its upcoming report, which could boost investor confidence and stock price.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Jefferies analysts recommend that prudent investment portfolios incorporate a ballast element for stability, according to a recent research note.
Why It Matters
The mention of "ballast" suggests a focus on risk management in portfolios, indicating a potential shift towards safer investments amid market volatility, impacting asset allocations.
Source: Barrons
Market Sentiment:
Positive
Health insurers raise questions about Medicare program that will offer GLP-1s to seniors for $50
1 day ago
Quick Summary
Health insurers are opposing a new Medicare program that would enable beneficiaries to pay $50 monthly for GLP-1 weight loss medications.
Why It Matters
Health insurers opposing the program may impact their profitability and costs. This could affect stock prices and investment strategies in the healthcare sector.
Source: Market Watch
Market Sentiment:
Negative
Quick Summary
Over 500 CVS Health drivers and warehouse workers in Fredericksburg, Virginia, have voted to authorize a strike set for May 1, according to the International Brotherhood of Teamsters.
Why It Matters
A potential strike at CVS Health could disrupt operations, impacting supply chains and revenue. Investor sentiment may shift based on labor stability and operational efficiency concerns.
Source: Reuters
Market Sentiment:
Negative
Quick Summary
CVS Health (CVS) is currently attracting significant interest from Zacks.com users, indicating potential factors that may influence its stock performance.
Why It Matters
Increased attention from users may indicate rising interest or sentiment towards CVS, potentially influencing stock volatility and investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
CVS Health offers a more diversified business model compared to Novo Nordisk, with each having distinct advantages and disadvantages.
Why It Matters
CVS Health's diversification may offer stability and growth opportunities, while Novo Nordisk’s focus could yield higher returns in its niche, impacting investment strategies and risk assessments.
Source: The Motley Fool
Market Sentiment:
Neutral
Frequently Asked Questions About CVS Stock
What is CVS Health Corporation's (CVS) stock forecast for 2026?
Based on our analysis of 43 Wall Street analysts, CVS Health Corporation (CVS) has a median price target of $96.00. The highest price target is $140.00 and the lowest is $79.00.
Is CVS stock a good investment in 2026?
According to current analyst ratings, CVS has 24 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $77.36. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CVS stock?
Wall Street analysts predict CVS stock could reach $96.00 in the next 12 months. This represents a 24.1% increase from the current price of $77.36. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is CVS Health Corporation's business model?
CVS Health Corporation generates revenue through various segments, including retail pharmacy, pharmacy benefits management, and health insurance services. The company operates the largest retail pharmacy chain in the U.S., fills a significant portion of prescriptions, and provides pharmacy benefits management services to employers and insurers, along with health insurance through Aetna.
What is the highest forecasted price for CVS CVS Health Corporation?
The highest price target for CVS is $140.00 from at , which represents a 81.0% increase from the current price of $77.36.
What is the lowest forecasted price for CVS CVS Health Corporation?
The lowest price target for CVS is $79.00 from Kevin Caliendo at UBS, which represents a 2.1% increase from the current price of $77.36.
What is the overall CVS consensus from analysts for CVS Health Corporation?
The overall analyst consensus for CVS is bullish. Out of 43 Wall Street analysts, 24 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $96.00.
How accurate are CVS stock price projections?
Stock price projections, including those for CVS Health Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 22, 2026 7:14 AM UTC